UNSPSC 51453012: Piperazine hydrate

This classification denotes an antihelminthic agent with the molecular formula C4H10N2.6H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier P3M07B8U64, chemically known as 1,4-piperazine but more generally known as piperazine hydrate, which bears US NIH Compound Identifier 4837. European Medicines Agency schedules Piperazine hydrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12218MIG. Most nations, for tariff and trade purposes, schedule piperazine hydrate under HS 29335990.

As of Q4 2014, PIPERAZINE HYDRATE remains US FDA's Preferred Term for this commodity. SMILES: C1CNCCN1.O.

UNSPSC 51453012 Piperazine hydrate, a Commodity code, shows minimal alignment with recent state and local procurement activity. The code nominally addresses a specific chemical compound, but the recent opportunities posted under this classification involve pharmaceutical procurement and medical supply distribution at substantially broader scope — naloxone and drug deactivation systems, generic multi-source pharmaceuticals and OTC products, and therapeutic pharmacy initiatives — none of which directly concern piperazine hydrate as a discrete line item or primary procurement driver. State and local governments appear to be using this code as a catch-all categorization for pharmaceutical and medical chemical acquisitions rather than targeting piperazine hydrate specifically. Issuing bodies include county health departments (Seminole County, Florida), state HHS commissions (Texas), cities (Tampa), and cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance), though the code does not show repeat-buyer concentration across recent opportunities.

Recent activity spans Florida, Texas, Minnesota with interstate reach (Oregon participation in MMCAP), and the City of Tampa. Representative opportunities include Seminole County's IFB 60459723LAS for naloxone and drug deactivation systems with a response deadline of July 26, 2023 (note: the posted date of June 30, 2026 conflicts with the stated deadline year, creating ambiguity about currency); the City of Tampa's IFB 26-P-00145 for medical and first aid supplies to the Tampa Fire Department Rescue Division, due March 13, 2026, with an estimated contract value of $700,000 and a certified Small Local Business Enterprise set-aside; and the Minnesota Multistate Cooperative Purchasing Alliance RFP S1070000015802 for generic multi-source pharmaceuticals and OTC products, due March 26, 2026, serving multiple states. The code does not demonstrate a consistent recent procurement signal tied to piperazine hydrate as a distinct product category.